Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 150594
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Chemicals and Materials

Scope of the Report:

This report focuses on the Oral Solid Dosage Forms (OSDF) and Pharma Excipients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

ABITEC Corporation

AkzoNobel

Archer Daniels Midland (ADM)

BASF

DOW Chemical Company

Evonik

J.M. Huber Corporation

Cargill

Eastman Chemical Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Glycerin

Propylene Glycol

Sorbitol

Mannitol

Others

Market Segment by Applications, can be divided into

Industrial Application

Non-industrial Application

There are 15 Chapters to deeply display the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market.

Chapter 1, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, with sales, revenue, and price of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oral Solid Dosage Forms (OSDF) and Pharma Excipients market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Introduction

1.2 Market Analysis by Type

1.2.1 Glycerin

1.2.2 Propylene Glycol

1.2.3 Sorbitol

1.2.4 Mannitol

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Industrial Application

1.3.2 Non-industrial Application

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ABITEC Corporation

2.1.1 Business Overview

2.1.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AkzoNobel

2.2.1 Business Overview

2.2.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Archer Daniels Midland (ADM)

2.3.1 Business Overview

2.3.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 BASF

2.4.1 Business Overview

2.4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 DOW Chemical Company

2.5.1 Business Overview

2.5.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 DOW Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Evonik

2.6.1 Business Overview

2.6.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 J.M. Huber Corporation

2.7.1 Business Overview

2.7.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Cargill

2.8.1 Business Overview

2.8.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Eastman Chemical Company

2.9.1 Business Overview

2.9.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2017

3.3.2 Top 6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Analysis by Regions

4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Regions

4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Regions (2013-2018)

4.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

4.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

4.5 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

5 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Countries

5.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Countries

5.1.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Countries (2013-2018)

5.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

5.3 Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

5.4 Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

6 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Countries

6.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Countries

6.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

6.3 UK Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

6.4 France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

6.5 Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

6.6 Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Countries

7.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Countries (2013-2018)

7.2 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

7.3 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

7.4 Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

7.5 India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

8 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Countries

8.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Countries

8.1.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

8.3 Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

8.4 Colombia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Countries

9.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

9.3 UAE Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

9.4 Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

9.5 Nigeria Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

9.6 South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2013-2018)

10 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Segment by Type

10.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Type (2013-2018)

10.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Type (2013-2018)

10.2 Glycerin Sales Growth and Price

10.2.1 Global Glycerin Sales Growth (2013-2018)

10.2.2 Global Glycerin Price (2013-2018)

10.3 Propylene Glycol Sales Growth and Price

10.3.1 Global Propylene Glycol Sales Growth (2013-2018)

10.3.2 Global Propylene Glycol Price (2013-2018)

10.4 Sorbitol Sales Growth and Price

10.4.1 Global Sorbitol Sales Growth (2013-2018)

10.4.2 Global Sorbitol Price (2013-2018)

10.5 Mannitol Sales Growth and Price

10.5.1 Global Mannitol Sales Growth (2013-2018)

10.5.2 Global Mannitol Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Segment by Application

11.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2013-2018)

11.2 Industrial Application Sales Growth (2013-2018)

11.3 Non-industrial Application Sales Growth (2013-2018)

12 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Growth Rate (2018-2023)

12.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Regions (2018-2023)

12.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.2.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.2.4 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2018-2023)

12.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Type (2018-2023)

12.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2018-2023)

12.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Type (2018-2023)

12.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Application (2018-2023)

12.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2018-2023)

12.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Oral Solid Dosage Forms (OSDF) and Pharma Excipients Picture

Table Product Specifications of Oral Solid Dosage Forms (OSDF) and Pharma Excipients

Figure Global Sales

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery